View in EDS

Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study.

Saved in:
Bibliographic Details
Title: Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study.
Authors: Moreau P; University Hospital, Nantes, France philippe.moreau@chu-nantes.fr., Pylypenko H; Cherkassy Regional Oncology Dispensary, Cherkassy, Ukraine., Grosicki S; Medical University of Silesia, Katowice, Poland., Karamanesht I; Kiev BMT Center, Kiev, Ukraine., Leleu X; Hopital Huriez, CHRU, Lille, France., Rekhtman G; Khmelnitskiy Regional Hospital, Khmelnitskiy, Ukraine., Masliak Z; SI Institute of Blood Pathology and Transfusion Medicine UAMS, Lviv, Ukraine., Robak P; Medical University of Lodz, Lodz, Poland., Esseltine DL; Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA., Feng H; Janssen Research & Development, LLC, Raritan, NJ, USA., Deraedt W; Janssen Research & Development, Division of Janssen Pharmaceutica NV, Beerse, Belgium., van de Velde H; Janssen Research & Development, Division of Janssen Pharmaceutica NV, Beerse, Belgium., Arnulf B; Immuno-hématologie Department, Hôpital Saint-Louis, Paris, France.
Source: Haematologica [Haematologica] 2015 May; Vol. 100 (5), pp. e207-10. Date of Electronic Publication: 2015 Jan 16.
Publication Type: Clinical Trial, Phase III; Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 25596270
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Moreau+P%22">Moreau P</searchLink>; University Hospital, Nantes, France philippe.moreau@chu-nantes.fr.<br /><searchLink fieldCode="AU" term="%22Pylypenko+H%22">Pylypenko H</searchLink>; Cherkassy Regional Oncology Dispensary, Cherkassy, Ukraine.<br /><searchLink fieldCode="AU" term="%22Grosicki+S%22">Grosicki S</searchLink>; Medical University of Silesia, Katowice, Poland.<br /><searchLink fieldCode="AU" term="%22Karamanesht+I%22">Karamanesht I</searchLink>; Kiev BMT Center, Kiev, Ukraine.<br /><searchLink fieldCode="AU" term="%22Leleu+X%22">Leleu X</searchLink>; Hopital Huriez, CHRU, Lille, France.<br /><searchLink fieldCode="AU" term="%22Rekhtman+G%22">Rekhtman G</searchLink>; Khmelnitskiy Regional Hospital, Khmelnitskiy, Ukraine.<br /><searchLink fieldCode="AU" term="%22Masliak+Z%22">Masliak Z</searchLink>; SI Institute of Blood Pathology and Transfusion Medicine UAMS, Lviv, Ukraine.<br /><searchLink fieldCode="AU" term="%22Robak+P%22">Robak P</searchLink>; Medical University of Lodz, Lodz, Poland.<br /><searchLink fieldCode="AU" term="%22Esseltine+DL%22">Esseltine DL</searchLink>; Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Feng+H%22">Feng H</searchLink>; Janssen Research & Development, LLC, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Deraedt+W%22">Deraedt W</searchLink>; Janssen Research & Development, Division of Janssen Pharmaceutica NV, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22van+de+Velde+H%22">van de Velde H</searchLink>; Janssen Research & Development, Division of Janssen Pharmaceutica NV, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Arnulf+B%22">Arnulf B</searchLink>; Immuno-hématologie Department, Hôpital Saint-Louis, Paris, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220417435%22">Haematologica</searchLink> [Haematologica] 2015 May; Vol. 100 (5), pp. e207-10. <i>Date of Electronic Publication: </i>2015 Jan 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Letter; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ferrata+Storti+Foundation%22">Ferrata Storti Foundation </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>0417435 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1592-8721 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203906078%22">03906078 </searchLink><i>NLM ISO Abbreviation: </i>Haematologica <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25596270
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3324/haematol.2014.118182
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e207
    Titles:
      – TitleFull: Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Moreau P
      – PersonEntity:
          Name:
            NameFull: Pylypenko H
      – PersonEntity:
          Name:
            NameFull: Grosicki S
      – PersonEntity:
          Name:
            NameFull: Karamanesht I
      – PersonEntity:
          Name:
            NameFull: Leleu X
      – PersonEntity:
          Name:
            NameFull: Rekhtman G
      – PersonEntity:
          Name:
            NameFull: Masliak Z
      – PersonEntity:
          Name:
            NameFull: Robak P
      – PersonEntity:
          Name:
            NameFull: Esseltine DL
      – PersonEntity:
          Name:
            NameFull: Feng H
      – PersonEntity:
          Name:
            NameFull: Deraedt W
      – PersonEntity:
          Name:
            NameFull: van de Velde H
      – PersonEntity:
          Name:
            NameFull: Arnulf B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2015 May
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 1592-8721
          Numbering:
            – Type: volume
              Value: 100
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Haematologica
              Type: main
ResultId 1